Eugia Pharma Specialities Limited Letrozole Export Data — India (DGFT 2022–2026)

Name: Eugia Pharma Specialities Limited Letrozole Export Records India — #4 Exporter, 119 Shipments, $1.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Letrozole

India Pharmaceutical Trade Intelligence

$32.1M252 Suppliers117 CountriesHS 30049049

ExportsIndia → THAILAND48.3%India → UNITED STATES12.1%

ImportsSWITZERLAND → India$30.9K BELGIUM → India$7.4K

#1 Supplier: CIPLA LIMITED

Eugia Pharma Specialities Limited — Letrozole Exporter #4 | $1.8M Trade Value | TransData Nexus | TransData Nexus

Eugia Pharma Specialities Limited — Letrozole Exporter Profile

Indian Pharmaceutical Exporter · #4 for Letrozole · $1.8M export value · DGFT Verified

Eugia Pharma Specialities Limited is the #4 Indian exporter of Letrozole with $1.8M in export value and 119 verified shipments. Eugia Pharma Specialities Limited holds a 5.7% market share in Letrozole exports across 9 countries. The company exports 49 pharmaceutical products worth $170.1M across 14 therapeutic categories.

Eugia Pharma Specialities Limited — Letrozole Export Profile: Buyers & Destinations

Eugia Pharma Specialities Limited Letrozole export treemap — buyers and destination countries | TransData Nexus

Where Does Eugia Pharma Specialities Limited Export Letrozole?

Country	Value	Shipments	Share
UNITED STATES	$825.4K	31	49.1%
MALTA	$453.7K	57	27.0%
CHILE	$136.6K	5	8.1%
MALAYSIA	$118.3K	4	7.0%
TANZANIA

Who Are the Top Buyers of Letrozole from Eugia Pharma Specialities Limited?

Buyer	Country	Value	Orders
AUROBINDO PHARMA USA., INC,	UNITED STATES	$418.6K	18
AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$178.8K	7
EUGIA PHARMA (MALTA) LTD,	MALTA	$161.4K	20
AUROBINDO PHARMA USA INC	UNITED STATES	$154.0K	4
EUGIA PHARMA MALTA LIMITED	MALTA	$93.1K	8
SIRON PHARMA SPA	CHILE	$89.0K	3
EUGIA PHARMA (MALTA) LTD	MALTA	$79.2K	16
SYNERRV SDN BHD,	MALAYSIA	$61.4K	2
SYNERRV SDN BHD	MALAYSIA	$56.9K	2
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$54.3K	4

Eugia Pharma Specialities Limited supplies Letrozole to 26 buyers globally. The largest buyer is AUROBINDO PHARMA USA., INC, (UNITED STATES), followed by AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES) and EUGIA PHARMA (MALTA) LTD, (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Letrozole Formulations Does Eugia Pharma Specialities Limited Export?

Product Description / Formulation	Value	Shipments
LETROZOLE TABLETS 2.5MG (LETROZOLE TABLE	$242.7K	7
LETROZOLE TABLETS 2.5MG	$66.6K	2
LETROZOLE TABLETS 2.5MG LETROZOLE TABLETS USP 2.5MG FOR 30 S COUNT US QTY: 71955 PACKS	$50.0K	1
LETROZOLE TABLETS 2.5MG LETROZOLE TABLETS USP 2.5MG FOR 30S COUNT US QTY: 71485 PACKS	$50.0K	1
LETROZOLE TABLETS 2 5MG LETRODAY 2 5 Malaysia 29659 PACK	$50.0K	1
LETROZOLE TABLETS 2.5MG (Letrozole 2.5 mg Tablets - Germany (10x10's Blister)	$48.8K	2
LETROZOLE TABLETS 2.5MG (LETRODAY 2.5) (3000 PACK)	$43.4K	3
LETROZOLE TABLETS 2.5MG (35505X30'S)NOS	$40.2K	3
LETROZOLE TABLETS 2.5MG 35674X30'S	$40.1K	1
LETROZOLE TABLETS 2.5MG (35101X30'S)	$39.0K	1

Eugia Pharma Specialities Limited exports 80 distinct Letrozole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LETROZOLE TABLETS 2.5MG (LETROZOLE TABLE with 7 shipments worth $242.7K.

How Does Eugia Pharma Specialities Limited Compare to Nearest Letrozole Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	CIPLA LIMITED	$4.1M	82	6	$50.0K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$2.4M	56	8	$43.3K
4	EUGIA PHARMA SPECIALITIES LIMITED ★	$1.8M	119	9	$15.3K
5	ZYDUS LIFESCIENCES LIMITED	$739.2K	35	7	$21.1K
6	NAPROD LIFE SCIENCES PRIVATE LIMITED	$581.6K	12	2	$48.5K

Eugia Pharma Specialities Limited ranks #4 among 252 Indian Letrozole exporters. Average shipment value of $15.3K compared to the market average of $74.0K. The closest competitors by value are CIPLA LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Letrozole Exports?

Port	Shipments	% Share
SAHAR AIR	404	19.1%
SAHAR AIR CARGO ACC (INBOM4)	393	18.6%
MUNDRA SEA (INMUN1)	109	5.2%
AHEMDABAD AIR ACC (INAMD4)	107	5.1%
MUNDRA SEA	102	4.8%
DELHI AIR CARGO ACC (INDEL4)	100	4.7%
Bombay Air	99	4.7%
HYDERABAD AIR	89	4.2%

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Letrozole Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Eugia. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical hurdles are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have opened avenues for Indian exporters. With the U.S. seeking to diversify its supply chains away from China, Indian pharmaceutical companies have the opportunity to capture a larger share of the U.S. market. Eugia's recent FDA approvals and product launches position it well to capitalize on this shift.

However, the imposition of new tariffs by the U.S. administration in August 2025, affecting over 60 countries including India, poses a significant challenge. These tariffs, reaching up to 39%, could impact nearly 55% of India's exports to the U.S., including pharmaceuticals. The increased cost burden may erode profit margins and affect competitiveness in the U.S. market. (apnews.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must ensure stringent adherence to serialization and traceability standards to maintain access to the EU market. Eugia's commitment to quality and regulatory compliance will be pivotal in navigating these regulatory landscapes.

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the USFDA intensifying inspections and compliance requirements. Eugia's experience with the USFDA's warning letter for its Unit-III facility underscores the importance of robust quality management systems. Addressing these regulatory observations is crucial for maintaining market access and reputation.

Indian pharmaceutical companies, including Eugia, are investing in upgrading manufacturing practices to meet international standards. This proactive approach is essential to mitigate risks associated with non-compliance and to sustain growth in regulated markets.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Letrozole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Eugia Pharma Specialities Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 119 individual customs records matching Eugia Pharma Specialities Limited exporting Letrozole, covering 80 formulations to 9 countries via 26 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 117+ countries, 508+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Letrozole

Letrozole

Eugia Pharma Specialities Limited — Letrozole Exporter Profile

Eugia Pharma Specialities Limited — Letrozole Export Profile: Buyers & Destinations

Where Does Eugia Pharma Specialities Limited Export Letrozole?

Who Are the Top Buyers of Letrozole from Eugia Pharma Specialities Limited?

What Is India's Total Letrozole Export Value and How Much Does Eugia Pharma Specialities Limited Contribute?

What Is the Average Shipment Value for Eugia Pharma Specialities Limited's Letrozole Exports?

How Does Eugia Pharma Specialities Limited Compare to Other Indian Letrozole Exporters?

What Letrozole Formulations Does Eugia Pharma Specialities Limited Export?

Regulatory Requirements: Exporting Letrozole to Key Markets

United States — FDA

How Does Eugia Pharma Specialities Limited Compare to Nearest Letrozole Exporters?

Which Indian Ports Ship Letrozole Exports?

What Other Advanced Oncology Products Does Eugia Pharma Specialities Limited Export?

Letrozole — Export Intelligence Video

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Letrozole Exports

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

About Eugia Pharma Specialities Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Letrozole Export Data from Eugia Pharma Specialities Limited

Letrozole Stats

Company Overview

Top Products by Eugia Pharma Specialities Limited

Related Analysis

Need Detailed Export Data?

Data Source